» Articles » PMID: 27376446

Cardiac Autonomic Functioning is Impaired Among Allogeneic Hematopoietic Stem Cell Transplantation Survivors: a Controlled Study

Overview
Specialty General Surgery
Date 2016 Jul 5
PMID 27376446
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Healthy cardiac autonomic functioning (CAF) is essential for maintaining homeostasis in response to the environmental demands of everyday life. Impaired CAF is associated with higher morbidity and higher mortality. To explore CAF in survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT) 1-10 years after transplant (median=4.3 years), an ambulatory assessment was performed with 104 patients, and 45 age- and gender-matched healthy controls. Heart rate (HR) and respiratory sinus arrhythmia (RSA, that is, high-frequency HR variability) were measured in a laboratory setting and during a 12-hour naturalistic period of daily life. Cancer-related fatigue was assessed by the Functional Assessment of Chronic Illness - Fatigue questionnaire; physical fitness by bicycle-ergometry VOmax. In contrast to healthy controls, 4-year post-HSCT fatigue was greater in patients (P<0.0001, Cohen's d effect size [d]=1.14), and fitness was lower in patients (P<0.0001, d=1.09). In both laboratory and real-life ambulatory conditions, average HR was persistently higher (P<0.0001, d=0.88) and mean RSA magnitude lower (P<0.001, d=0.69) among patients, compared with controls. Severely fatigued patients showed higher HR and lower parasympathetic cardiac control than non-fatigued patients (HR: P=0.02, d=0.47; RSA: P=0.02, d=0.72), and this was unrelated to fitness. These findings may have important implications for predicting long-term treatment outcome and consequences for routine post-HSCT care.

Citing Articles

Heart Rate Variability as a Digital Biomarker in Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation.

Taylor M, Bradford M, Zhou C, Fladeboe K, Wittig J, Baker K Cancer Med. 2025; 14(4):e70609.

PMID: 39981705 PMC: 11843223. DOI: 10.1002/cam4.70609.


Orthostatic intolerance syndromes after hematopoietic cell transplantation: clinical characteristics and therapeutic interventions in a single-center experience.

Vecchie A, Thomas G, Bressi E, Bonaventura A, Canada J, Chuquin D Cardiooncology. 2021; 7(1):40.

PMID: 34847948 PMC: 8630909. DOI: 10.1186/s40959-021-00126-7.


Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association.

Fradley M, Beckie T, Brown S, Cheng R, Dent S, Nohria A Circulation. 2021; 144(3):e41-e55.

PMID: 34134525 PMC: 8992663. DOI: 10.1161/CIR.0000000000000986.


Quantitative assessment of cardiovascular autonomic impairment in cancer survivors: a single center case series.

Noor B, Akhavan S, Leuchter M, Yang E, Ajijola O Cardiooncology. 2020; 6:11.

PMID: 32742722 PMC: 7388471. DOI: 10.1186/s40959-020-00065-9.

References
1.
Viniegra M, Marchetti M, Losso M, Navigante A, Litovska S, Senderowicz A . Cardiovascular autonomic function in anthracycline-treated breast cancer patients. Cancer Chemother Pharmacol. 1990; 26(3):227-31. DOI: 10.1007/BF02897205. View

2.
Grossman P . The LifeShirt: a multi-function ambulatory system monitoring health, disease, and medical intervention in the real world. Stud Health Technol Inform. 2005; 108:133-41. View

3.
Lawrence D, Kupelnick B, Miller K, Devine D, Lau J . Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004; (32):40-50. DOI: 10.1093/jncimonographs/lgh027. View

4.
Martin R, Delgado J, Molto J, Vicent J, Manzanares R, Insa R . Cardiovascular reflexes in patients with malignant disease. Ital J Neurol Sci. 1992; 13(2):125-9. DOI: 10.1007/BF02226960. View

5.
Bower J, Bak K, Berger A, Breitbart W, Escalante C, Ganz P . Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol. 2014; 32(17):1840-50. PMC: 4039870. DOI: 10.1200/JCO.2013.53.4495. View